Merck & Co., Inc. (MRK) to Hold Second-Quarter 2013 Sales and Earnings Conference Call on July 30
6/28/2013 9:27:17 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
Merck (NYSE: MRK), known as MSD outside the United States and Canada, will hold its second-quarter 2013 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. EDT on Tuesday, July 30. During the call, Kenneth C. Frazier, chairman and chief executive officer; Peter N. Kellogg, executive vice president and chief financial officer; and Adam H. Schechter, president, Global Human Health, will provide an overview of Merck’s financial performance for the quarter.
Help employers find you! Check out all the jobs and post your resume.
comments powered by